Brandywine Oak Private Wealth LLC Novo Nordisk A S Transaction History

Brandywine Oak Private Wealth LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$103.24 - $121.81 $13,834 - $16,322	134 Added 4.09%	3,414 $380,000
Q1 2022 May 02, 2022	SELL	$93.1 - $112.54 $29,233 - $35,337	-314 Reduced 8.74%	3,280 $363,000
Q4 2021 Feb 07, 2022	SELL	$95.88 - $117.08 $50,528 - $61,701	-527 Reduced 12.79%	3,594 $402,000
Q3 2021 Oct 18, 2021	SELL	$84.42 - $106.62 $19,669 - $24,842	-233 Reduced 5.35%	4,121 $387,000
Q2 2021 Aug 09, 2021	SELL	$67.66 - $84.76 $31,258 - $39,159	-462 Reduced 9.59%	4,354 $364,000
Q1 2021 May 06, 2021	SELL	$67.06 - $75.82 $9,924 - $11,221	-148 Reduced 2.98%	4,816 $324,000
Q4 2020 Feb 08, 2021	SELL	$63.89 - $73.8 $56,350 - $65,091	-882 Reduced 15.09%	4,964 $346,000
Q3 2020 Oct 16, 2020	SELL	$63.69 - $70.22 $9,043 - $9,971	-142 Reduced 2.37%	5,846 $405,000
Q2 2020 Aug 06, 2020	BUY	$58.54 - $67.94 $72,940 - $84,653	1,246 Added 26.28%	5,988 $392,000
Q1 2020 May 06, 2020	SELL	$49.46 - $64.78 $24,482 - $32,066	-495 Reduced 9.45%	4,742 $285,000
Q4 2019 Jan 28, 2020	SELL	$49.86 - $58.26 $6,830 - $7,981	-137 Reduced 2.55%	5,237 $303,000
Q3 2019 Oct 30, 2019	BUY	$47.54 - $53.43 $6,560 - $7,373	138 Added 2.64%	5,374 $277,000
Q2 2019 Jul 22, 2019	SELL	$46.79 - $52.47 $3,415 - $3,830	-73 Reduced 1.38%	5,236 $267,000
Q1 2019 May 09, 2019	SELL	$46.36 - $52.63 $29,855 - $33,893	-644 Reduced 10.82%	5,309 $277,000
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $247,287 - $281,279	5,953 New	5,953 $274,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Brandywine Oak Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Brandywine Oak Private Wealth LLC with notifications on news.